Merrimack Pharmaceuticals, Inc.

Industry / private company


Location: Cambridge, MA, United States (USA) (US) US

ISNI: 000000404102266

ROR: https://ror.org/034dw6775

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany (2020) Hübner H, Kurbacher CM, Kuesters G, Hartkopf AD, Lux MP, Huober J, Volz B, et al. Journal article Use of a molecular Registry (PRAEGNANT) for Patient-Selection and Biomarker-Analysis for the SHERBOC Study (2020) Hübner H, Kurbacher C, Kuesters G, Hartkopf AD, Lux MP, Huober J, Volz B, et al. Conference contribution Model based targeting of IL-6-induced inflammatory responses in cultured primary hepatocytes to improve application of the JAK inhibitor ruxolitinib (2017) Sobotta S, Raue A, Huang X, Vanlier J, Juenger A, Bohl S, Albrecht U, et al. Journal article CERENA: ChEmical REaction network analyzer-a toolbox for the simulation and analysis of stochastic chemical kinetics (2016) Kazeroonian A, Froehlich F, Raue A, Theis FJ, Hasenauer J Journal article Data2Dynamics: A modeling environment tailored to parameter estimation in dynamical systems (2015) Raue A, Steiert B, Schelker M, Kreutz C, Maiwald T, Hass H, Vanlier J, et al. Journal article Lessons Learned from Quantitative Dynamical Modeling in Systems Biology (2013) Raue A, Schilling M, Bachmann J, Matteson A, Schelke M, Kaschek D, Hug S, et al. Journal article